PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study sheds light on precise personalized hepatocellular carcinoma medicine

Study sheds light on precise personalized hepatocellular carcinoma medicine
2021-07-12
(Press-News.org) A research group led by Prof. PIAO Hailong from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences (CAS) identified hepatocellular carcinoma (HCC) subtypes with distinctive metabolic phenotypes through bioinformatics and machine learning methods, and elucidated the potential mechanisms based on a metabolite-protein interaction network and multi-omics data.

The study, published in Advanced Science on July 11, provides insights guiding precise personalized HCC medicine.

Metabolic reprogramming, which can promote rapid cell proliferation by regulating energy and nutrient metabolism, is considered to be one hallmark of cancer. It can impact other biological processes through complex metabolite-protein interactions.

The researchers utilized complex network and machine learning methods to analyze multi-omics data and the metabolite-protein interaction network to identify hepatocellular carcinoma subtypes with significant differences in prognosis.

They identified a metabolic HCC subtype with poor prognosis, which is strongly correlated with hypoxia, hypermethylation of metabolic enzymes, down-regulation of various metabolic pathways, and accumulation of multiple fatty acids. In addition, many immune-related pathways were significantly up-regulated in this poor prognosis subtype.

Based on further analyses of metabolite-protein interactions, the researchers predicted multiple interactions between unsaturated fatty acid and immunoregulatory proteins, suggesting that unsaturated fatty acid accumulation may be one potential cause of immune pathway up-regulation.

INFORMATION:


[Attachments] See images for this press release:
Study sheds light on precise personalized hepatocellular carcinoma medicine

ELSE PRESS RELEASES FROM THIS DATE:

Want to avoid running overuse injuries? Don't lean forward so much, says CU Denver study

2021-07-12
The ubiquitous overuse injuries that nag runners may stem from an unlikely culprit: how far you lean forward. Trunk flexion, the angle at which a runner bends forward from the hip, can range wildly--runners have self-reported angles of approximately -2 degrees to upward of 25. A new study from the END ...

Heart risk 'calculators' overlook increased risk for people of South Asian ancestry

2021-07-12
DALLAS, July 12, 2021 -- People of South Asian ancestry have more than double the risk of developing heart disease compared to people of European ancestry, yet clinical risk assessment calculators used to guide decisions about preventing or treating heart disease may fail to account for the increased risk, according to new research published today in the American Heart Association's flagship journal Circulation. About a quarter of the world's population (1.8 billion people) are of South Asian descent, and prior research has shown South Asians experience higher rates of heart disease compared to people of most other ethnicities. To better understand the variables surrounding the heart disease risk for people of South Asian ancestry, researchers evaluated ...

Innovative gene therapy 'reprograms' cells to reverse neurological deficiencies

2021-07-12
A novel method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities. The study, led by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine, offers new hope to those living with incurable genetic and neurodegenerative diseases. Research findings are published online in the journal Nature Communications. This study describes the findings from the targeted delivery of gene therapy to midbrain to treat a rare ...

USC researchers discover better way to identify DNA variants

2021-07-12
USC researchers have achieved a better way to identify elusive DNA variants responsible for genetic changes affecting cell functions and diseases. Using computational biology tools, scientists at the university's Dornsife College of Letters, Arts and Sciences studied "variable-number tandem repeats" (VNTR) in DNA. VNTRs are stretches of DNA made of a short pattern of nucleotides repeated over and over, like a plaid pattern shirt. Though they comprise but 3% of the human genome, the repetitive DNA governs how some genes are encoded and levels of proteins are produced in a cell, and account for most of the structural variation. Current methods do not accurately detect the variations in genes in some repetitive ...

Scientists blueprint bacterial enzyme believed to "stealthily" suppress immune response

2021-07-12
Scientists have produced the first fine-detail molecular blueprints of a bacterial enzyme known as Lit, which is suspected to play a "stealthy" role in the progression of infection by reducing the immune response. Blueprints such as these allow drug designers to uncover potential weaknesses in bacterial arsenals as they seek to develop new therapeutics that may help us win the war against antibiotic resistance. The study, led by scientists from the School of Biochemistry and Immunology and the Trinity Biomedical Sciences Institute (TBSI) at Trinity College Dublin, has just been published by leading international journal Nature Communications. Lipoproteins and their role in ...

A Trojan horse could help get drugs past our brain's tough border patrol

2021-07-12
Sclerosis, Parkinson's Disease, Alzheimer's and epilepsy are but a few of the central nervous system disorders. They are also very difficult to treat, since the brain is protected by the blood-brain barrier. The blood-brain barrier works as a border wall between the blood and the brain, allowing just certain molecules to enter the brain. And whereas water and oxygen can get through, as can other substances such as alcohol and coffee. But it does block more than 99 percent of potentially neuroprotective compounds from reaching their targets in the brain. Now, ...

Just 25 mega-cities produce 52% of the world's urban greenhouse gas emissions

2021-07-12
In 2015, 170 countries worldwide adopted the Paris Agreement, with the goal limiting the average global temperature increase to 1.5°C. Following the agreement, many countries and cities proposed targets for greenhouse gas mitigation. However, the UNEP Emissions Gap Report 2020 shows that, without drastic and strict actions to mitigate the climate crisis, we are still heading for a temperature increase of more than 3°C by the end of the 21st century. A new study published in the journal Frontiers in Sustainable Cities presents the first global balance sheet of greenhouse gasses (GHGs) emitted by major cities around the world. The aim was to research and monitor the effectiveness of historical GHG reduction ...

Addressing social needs may help mitigate distress and improve the health of women with cancer

2021-07-12
A new study published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society, has identified unmet social needs in women with gynecologic cancer that could be addressed to improve care for patients and lessen disparities. For example, identifying patients who reported needing help with reading hospital materials resulted in the use of a cancer care navigator who provided patient education and support, facilitating physician-patient communication and adherence to care recommendations. The prospective survey-based ...

Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia

Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia
2021-07-12
Oncotarget published "Inhibitory effects of Tomivosertib in acute myeloid leukemia" which reported that the authors evaluated the therapeutic potential of the highly-selective MNK1/2 inhibitor Tomivosertib on AML cells. Tomivosertib was highly effective at blocking eIF4E phosphorylation on serine 209 in AML cells. Moreover, combination of Tomivosertib and Venetoclax resulted in synergistic anti-leukemic responses in AML cell lines. Mass spectrometry studies identified novel putative MNK1/2 interactors, while in parallel studies we demonstrated that MNK2 - RAPTOR - mTOR complexes are not disrupted by Tomivosertib. Overall, these Oncotarget findings demonstrate that Tomivosertib exhibits potent ...

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network
2021-07-12
Oncotarget published "Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network" which reported that the chemical modulators of Tau PTMs, such as kinase inhibitors and antibody-based therapeutics, have been developed, but natural compounds, as modulators of Tau PTMs are not much explored. These authors applied biophysical and biochemical techniques like fluorescence kinetics, oligomerization analysis and transmission electron microscopy to investigate the impact of EGCG on Tau glycation in vitro. EGCG inhibited methyl glyoxal -induced Tau glycation in vitro. EGCG potently inhibited MG-induced advanced glycation endproducts formation in neuroblastoma cells as well modulated the localization ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] Study sheds light on precise personalized hepatocellular carcinoma medicine